Chiara Sarlo

914 total citations
25 papers, 402 citations indexed

About

Chiara Sarlo is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chiara Sarlo has authored 25 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 8 papers in Genetics and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chiara Sarlo's work include Acute Myeloid Leukemia Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Chiara Sarlo is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Chiara Sarlo collaborates with scholars based in Italy. Chiara Sarlo's co-authors include Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Sergio Amadori, Adriano Venditti, Giovanni Del Poeta, Paolo de Fabritiis, Alessandra Spagnoli, Francesco Lo‐Coco and Paola Panetta and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Chiara Sarlo

23 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chiara Sarlo Italy	10	302	148	90	88	42	25	402
Hassan Sibai Canada	11	226 0.7×	72 0.5×	118 1.3×	87 1.0×	59 1.4×	69	369
P G Cachia United Kingdom	10	212 0.7×	26 0.2×	82 0.9×	52 0.6×	33 0.8×	21	363
A Granda Spain	9	397 1.3×	39 0.3×	113 1.3×	98 1.1×	159 3.8×	11	447
T. Demirer Türkiye	7	213 0.7×	50 0.3×	49 0.5×	34 0.4×	116 2.8×	7	346
Ilaria Nichele Italy	11	142 0.5×	27 0.2×	209 2.3×	82 0.9×	64 1.5×	23	413
Guru Subramanian Guru Murthy United States	13	338 1.1×	114 0.8×	121 1.3×	137 1.6×	160 3.8×	81	520
Déborah Martı́nez-Baños Mexico	10	198 0.7×	15 0.1×	63 0.7×	115 1.3×	54 1.3×	24	316
Jaime Estrada United States	9	82 0.3×	104 0.7×	25 0.3×	54 0.6×	74 1.8×	14	343
E Vassallo Italy	11	150 0.5×	45 0.3×	48 0.5×	60 0.7×	66 1.6×	26	379
Gerald Gilchrist United States	8	458 1.5×	62 0.4×	92 1.0×	59 0.7×	38 0.9×	10	576

Countries citing papers authored by Chiara Sarlo

Since Specialization

Citations

This map shows the geographic impact of Chiara Sarlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Sarlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Sarlo more than expected).

Fields of papers citing papers by Chiara Sarlo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Sarlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Sarlo. The network helps show where Chiara Sarlo may publish in the future.

Co-authorship network of co-authors of Chiara Sarlo

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Sarlo. A scholar is included among the top collaborators of Chiara Sarlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Sarlo. Chiara Sarlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gini, Guido, Ombretta Annibali, Michela Sampaolo, et al.. (2019). Gonadal Function Recovery and Fertility in Women Treated with Chemo- and/or Radiotherapy for Hodgkin’s and Non-Hodgkin Lymphoma. Chemotherapy. 64(1). 36–41. 13 indexed citations

Annibali, Ombretta, Livia Piccioni, Chiara Sarlo, et al.. (2018). Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients. PLoS ONE. 13(7). e0200221–e0200221. 9 indexed citations

Principe, Maria Ilaria Del, Fabio Forghieri, Federica Lessi, et al.. (2018). Clinical Significance of Occult Central Nervous System Disease in Adult ACUTE Lymphoblastic Leukemia. a Multicenter,Report from the Campus ALL/Gimema Network. Blood. 132(Supplement 1). 658–658. 2 indexed citations

Buccisano, Francesco, Luca Maurillo, Alfonso Piciocchi, et al.. (2015). Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients. Annals of Hematology. 94(8). 1319–1326. 22 indexed citations

Annibali, Ombretta, Francesca Chiodi, Chiara Sarlo, et al.. (2015). R-COMP Regimen in B Cell Non Hodgkin Lymphoma Patients with Cardiovascular Comorbidities. Blood. 126(23). 5096–5096.

Principe, Maria Ilaria Del, Francesco Buccisano, Mariagiovanna Cefalo, et al.. (2014). High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma. Annals of Hematology. 93(9). 1509–1513. 26 indexed citations

Maurillo, Luca, Francesco Buccisano, Alfonso Piciocchi, et al.. (2014). Minimal residual disease as biomarker for optimal biologic dosing of ARA‐C in patients with acute myeloid leukemia. American Journal of Hematology. 90(2). 125–131. 12 indexed citations

Maurillo, Luca, Francesco Buccisano, Maria Ilaria Del Principe, et al.. (2013). TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS. Mediterranean Journal of Hematology and Infectious Diseases. 5(1). e2013032–e2013032. 3 indexed citations

Principe, Maria Ilaria Del, Francesco Buccisano, Luca Maurillo, et al.. (2013). Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia. Thrombosis Research. 132(5). 511–514. 41 indexed citations

10.

Sarlo, Chiara, Francesco Buccisano, Luca Maurillo, et al.. (2013). Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy. PubMed. 2013. 1–6. 17 indexed citations

11.

Venditti, Adriano, Francesco Buccisano, Luca Maurillo, et al.. (2013). Risk allocation of adult patients with non-M3 acute myeloid leukemia. Cineca Institutional Research Information System (Tor Vergata University). 2(1).

12.

Sarlo, Chiara, Selenia Campagna, Maria Ilaria Del Principe, et al.. (2010). Phase II Study of Bortezomib as a Single Agent In Patients with Relapsed/Refractory or De Novo Acute Myeloid Leukemia Unfit for Intensive Therapy. Blood. 116(21). 4360–4360. 1 indexed citations

13.

Poeta, Giovanni Del, Maria Ilaria Del Principe, Francesco Buccisano, et al.. (2009). The Amount of Spontaneous Apoptosis Is An Independent Strong Disease Progression Indicator in B-Cell Chronic Lymphocytic Leukemia (B-CLL). Blood. 114(22). 1252–1252. 1 indexed citations

14.

Maurillo, Luca, Francesco Buccisano, Maria Ilaria Del Principe, et al.. (2008). Toward Optimization of Postremission Therapy for Residual Disease–Positive Patients With Acute Myeloid Leukemia. Journal of Clinical Oncology. 26(30). 4944–4951. 125 indexed citations

15.

Buccisano, Francesco, Luca Maurillo, Anna Tamburini, et al.. (2007). Evaluation of the prognostic relevance of l‐selectin and ICAM1 expression in myelodysplastic syndromes. European Journal Of Haematology. 80(2). 107–114. 6 indexed citations

16.

Maurillo, Luca, Francesco Buccisano, Alessandra Spagnoli, et al.. (2007). Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow. Haematologica. 92(5). 605–611. 62 indexed citations

17.

Breccia, Massimo, Marco Mancini, Mauro Nanni, et al.. (2004). Clinical features of prognostic significance in myelodysplastic patients with normal karyotype at high risk of transformation. Leukemia Research. 29(1). 33–39. 7 indexed citations

18.

Breccia, Massimo, Gianna Maria D’Elia, G. Girelli, et al.. (2004). Paroxysmal cold haemoglobinuria as a tardive complication of idiopathic myelofibrosis. European Journal Of Haematology. 73(4). 304–306. 9 indexed citations

19.

Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2004). Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.. Blood. 104(11). 4693–4693. 1 indexed citations

20.

Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2004). Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment. Leukemia Research. 29(3). 287–291. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact